NeuroSense Announces First Quarter 2024 Business Update PR Newswire CAMBRIDGE, Mass., May 2, 2024 CAMBRIDGE, Mass., May 2, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN...
The following is a round-up of updates by global companies, issued on Thursday and Friday and not separately reported ...
The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...
The following is a round-up of updates by global companies, issued on Tuesday and not separately reported by Alliance ...
AstraZeneca PLC on Friday announced an agreement to sell its commercial rights to prescription medicines Atacand and ...
The following is a round-up of earnings and trading updates by Global companies, issued last week and not separately ...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 305.3 | 305.3 | 305.3 | 3985 | 305.3 | DE |
4 | 0 | 0 | 305.3 | 305.3 | 305.3 | 41841 | 305.3 | DE |
12 | 0 | 0 | 305.3 | 305.3 | 305.3 | 21547 | 305.3 | DE |
26 | 0 | 0 | 305.3 | 305.3 | 305.3 | 24990 | 305.3 | DE |
52 | 0 | 0 | 305.3 | 305.3 | 305.3 | 48477 | 305.3 | DE |
156 | 0 | 0 | 305.3 | 305.3 | 305.3 | 51316 | 305.3 | DE |
260 | 0 | 0 | 305.3 | 305.3 | 305.3 | 39792 | 305.3 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約